Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nickel ion (Ni2+) is a transition metal cation that serves as an essential cofactor for several microbial enzymes, including urease and NiFe-hydrogenase, which are vital for the survival and virulence of various pathogens (Boer et al., 2014, "Nickel metabolism in bacteria"). While nickel's essentiality in humans remains unproven, it is clinically significant as a potent allergen and a known human carcinogen (IARC Monographs, Volume 100C). Exposure to nickel ions frequently results in allergic contact dermatitis, a T-cell mediated immune response (StatPearls, "Nickel Allergy"). In cases of nickel toxicity or poisoning, the ion becomes a therapeutic target for chelating agents such as disulfiram (via its metabolite diethyldithiocarbamate) and edetate calcium disodium, which bind the metal to facilitate its renal clearance (PubChem, "Nickel(2+)"). Additionally, research into nickel-coordinating complexes has explored their potential as antimicrobial or anticancer agents, though their primary clinical relevance remains centered on toxicology and hypersensitivity management (Genchi et al., 2020, "Nickel: Human Health and Environmental Toxicology"). Chronic inhalation of nickel-containing dusts is specifically linked to squamous cell carcinoma of the lungs and ethmoid sinus (NIH, National Toxicology Program).
Chelation of the metal ion to form stable, water-soluble complexes that are subsequently excreted by the kidneys.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nickel(2+) ion (Ni2+).